Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?

[1]  P. V. van Diest,et al.  BRCA1 and BRCA2 germline mutation analysis in the Indonesian population , 2007, Breast Cancer Research and Treatment.

[2]  R. Fimmers,et al.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Hans H Schild,et al.  Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. , 2005, Radiology.

[4]  H. D. de Koning,et al.  Hereditary breast cancer growth rates and its impact on screening policy. , 2005, European journal of cancer.

[5]  R. Eeles,et al.  Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40. , 2005, European journal of cancer care.

[6]  Joan Leach,et al.  Expert heads a'rolling Melissa Leach Ian , 2005, The Lancet.

[7]  S. Narod,et al.  Time to reconsider subcutaneous mastectomy for breast-cancer prevention? , 2005, The Lancet. Oncology.

[8]  L. Esserman,et al.  MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. , 2005, AJR. American journal of roentgenology.

[9]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[10]  G. Porter,et al.  Ten years of breast screening in the Nova Scotia Breast Screening Program, 1991-2001. experience: use of an adaptable stereotactic device in the diagnosis of screening-detected abnormalities. , 2005, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[11]  M. Miyazaki,et al.  Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography , 2005, European Radiology.

[12]  J. Elmore,et al.  A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices. , 2005, Archives of internal medicine.

[13]  F. Podo,et al.  Women with history of breast cancer excluded from screening programs: is it the right choice? , 2005, Radiology.

[14]  Dianne Georgian-Smith,et al.  Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. , 2005, AJR. American journal of roentgenology.

[15]  J. Klijn,et al.  Efficacy of magnetic resonance imaging and mammography for breast cancer screening in women with a familial or genetic predisposition , 2005 .

[16]  R. Calderon-Margalit,et al.  Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: A critical review of the literature , 2004, International journal of cancer.

[17]  Massimo Bazzocchi,et al.  Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. , 2004, AJR. American journal of roentgenology.

[18]  Ellen Warner,et al.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.

[19]  W. Berg.  Image-guided breast biopsy and management of high-risk lesions. , 2004, Radiologic clinics of North America.

[20]  C. Sewell,et al.  Pathology of high-risk breast lesions and ductal carcinoma in situ. , 2004, Radiologic clinics of North America.

[21]  F. Sardanelli,et al.  Dynamic Breast Magnetic Resonance Imaging: Effect of Changing the Region of Interest on Early Enhancement Using 2D and 3D Techniques , 2004, Journal of computer assisted tomography.

[22]  W. Berg.  Supplemental screening sonography in dense breasts. , 2004, Radiologic clinics of North America.

[23]  R. Bisegna,et al.  Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  Christian Hintze,et al.  Combination of low and high resolution sequences in two orientations for dynamic contrast-enhanced MRI of the breast: more than a compromise , 2004, European Radiology.

[25]  H. D. de Koning,et al.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.

[26]  Uwe Fischer,et al.  The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer , 2004, European Radiology.

[27]  J. Weyler,et al.  Enhancing area surrounding breast carcinoma on MR mammography: comparison with pathological examination , 2004, European Radiology.

[28]  A. D. De Schepper,et al.  Preoperative breast MRI in patients with invasive lobular breast cancer , 2004, European Radiology.

[29]  W. A. Kaiser,et al.  Is the “blooming sign” a promising additional tool to determine malignancy in MR mammography? , 2004, European Radiology.

[30]  V. Vogel,et al.  Recognition and management of hereditary breast cancer syndromes. , 2004, The oncologist.

[31]  B. Friedenson.  Assessing and managing breast cancer risk: clinical tools for advising patients. , 2004, MedGenMed : Medscape general medicine.

[32]  C. Kuhl,et al.  Breast MR imaging during or soon after radiation therapy. , 2003, Radiology.

[33]  J. Coebergh,et al.  Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. , 2003, European journal of cancer.

[34]  Elizabeth A Morris,et al.  Fast MRI-guided vacuum-assisted breast biopsy: initial experience. , 2003, AJR. American journal of roentgenology.

[35]  A. Fausto,et al.  MR imaging of the breast: indications, established technique, and new directions , 2003, European Radiology.

[36]  M Thelen,et al.  Improved artificial neural networks in prediction of malignancy of lesions in contrast-enhanced MR-mammography. , 2003, Medical physics.

[37]  Elizabeth A Morris,et al.  MRI of occult breast carcinoma in a high-risk population. , 2003, AJR. American journal of roentgenology.

[38]  Elizabeth A Morris,et al.  Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. , 2003, Radiology.

[39]  Elizabeth A Morris,et al.  MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. , 2003, AJR. American journal of roentgenology.

[40]  D. Stoppa-Lyonnet,et al.  IMPACT OF GENE PATENTS ON THE COST-EFFECTIVE DELIVERY OF CARE: THE CASE OF BRCA1 GENETIC TESTING , 2003, International Journal of Technology Assessment in Health Care.

[41]  B. Weber,et al.  Application of breast cancer risk prediction models in clinical practice. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Jennifer B Kaplan,et al.  MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. , 2003, AJR. American journal of roentgenology.

[43]  G. Lenoir,et al.  Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. , 2002, Journal of the National Cancer Institute.

[44]  T. M. Kolb,et al.  Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. , 2002, Radiology.

[45]  C. Zuiani,et al.  The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. , 2002, Journal of experimental & clinical cancer research : CR.

[46]  Gordon B Mills,et al.  Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. , 2002, Journal of the National Cancer Institute.

[47]  P. Marano,et al.  Magnetic Resonance Imaging in Breast Cancer Recurrence , 2002, Breast Cancer Research and Treatment.

[48]  Susan L Neuhausen,et al.  Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.

[49]  J. Satagopan,et al.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. , 2002, The New England journal of medicine.

[50]  S. Heywang-Köbrunner,et al.  Suppression of Unspecific Enhancement on Breast Magnetic Resonance Imaging (Mri) by Antiestrogen Medication , 2002, Tumori.

[51]  L. Liberman,et al.  Preoperative MR imaging-guided needle localization of breast lesions. , 2002, AJR. American journal of roentgenology.

[52]  J. Satagopan,et al.  Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  E. Grabbe,et al.  Classification of hypervascularized lesions in CE MR imaging of the breast , 2002, European Radiology.

[54]  P. Chappuis,et al.  Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. , 2001, Journal of the National Cancer Institute.

[55]  S. Fosså,et al.  Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. , 2001, Journal of the National Cancer Institute.

[56]  T. Walsh,et al.  Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. , 2001, JAMA.

[57]  T. Sellers,et al.  Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. , 2001, Journal of the National Cancer Institute.

[58]  D B Plewes,et al.  Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  J. Klijn,et al.  Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. , 2001, The New England journal of medicine.

[60]  D. Bowen,et al.  Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[61]  J. Klijn,et al.  Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  S. Wurdinger,et al.  Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography , 2000, Breast Cancer Research.

[63]  D. Dershaw.  Mammographic screening of the high-risk woman. , 2000, American journal of surgery.

[64]  Matthijs Oudkerk,et al.  First experiences in screening women at high risk for breast cancer with MR imaging , 2000, Breast Cancer Research and Treatment.

[65]  D Krebs,et al.  Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. , 2000, Radiology.

[66]  R. Macmillan.  Screening women with a family history of breast cancer--results from the British Familial Breast Cancer Group. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[67]  E Grabbe,et al.  Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. , 1999, Radiology.

[68]  M H Gail,et al.  Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. , 1999, Journal of the National Cancer Institute.

[69]  D. Fraker,et al.  Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. , 1999, Radiology.

[70]  C. Kuhl,et al.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.

[71]  J. Thornby,et al.  The Life Span of Silicone Gel Breast Implants and a Comparison of Mammography, Ultrasonography, and Magnetic Resonance Imaging in Detecting Implant Rupture: A Meta‐analysis , 1998, Annals of plastic surgery.

[72]  C A Kelsey,et al.  Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. , 1998, Radiology.

[73]  M. Stratton,et al.  Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. , 1998, Journal of the National Cancer Institute.

[74]  H. D. de Koning,et al.  Radiation risk of mammography related to benefit in screening programmes: a favourable balance? , 1998, Journal of medical screening.

[75]  A. Howell,et al.  Screening by mammography, women with a family history of breast cancer. , 1998, European journal of cancer.

[76]  A. Del Maschio,et al.  MR state of the art. , 1998, European journal of radiology.

[77]  I. Ellis,et al.  Screening women aged less than 50 years with a family history of breast cancer. , 1998, European journal of cancer.

[78]  L. Norton,et al.  BRCA-associated breast cancer in young women. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[79]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[80]  E Grabbe,et al.  Magnetic Resonance Guided Localization and Biopsy of Suspicious Breast Lesions , 1998, Topics in magnetic resonance imaging : TMRI.

[81]  J. Klijn,et al.  Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 , 1998, The Lancet.

[82]  E. Franssen,et al.  Management of women at increased risk for breast cancer: preliminary results from a new program. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[83]  C K Kuhl,et al.  Interventional breast MR imaging: clinical use of a stereotactic localization and biopsy device. , 1997, Radiology.

[84]  M. Stratton.  Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.

[85]  A. Bowcock,et al.  Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. , 1997, The New England journal of medicine.

[86]  M. King,et al.  Population genetics of BRCA1 and BRCA2. , 1997, American journal of human genetics.

[87]  G. Eichele,et al.  Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.

[88]  E. Thomson,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .

[89]  K Offit,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. , 1997, JAMA.

[90]  M D Schnall,et al.  Breast MR imaging: interpretation model. , 1997, Radiology.

[91]  P. Tonin,et al.  Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? , 1997, American journal of human genetics.

[92]  S. Moss,et al.  Benefits versus risks from mammography. A critical reassessment. , 1997, Cancer.

[93]  A Heinig,et al.  Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. , 1997, European journal of radiology.

[94]  M. Schnall,et al.  High-resolution MR imaging of the breast: clinical context. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.

[95]  T. Merchant,et al.  Breast cancer induction due to mammographic screening in hereditarily affected women. , 1996, Anticancer research.

[96]  G. Lenoir,et al.  In-situ breast cancer and BRCA 1 , 1996, The Lancet.

[97]  W. Thompson,et al.  The genetic attributable risk of breast and ovarian cancer , 1996, Cancer.

[98]  U. Fischer,et al.  Das duktale In-situ-Karzinom in der dynamischen MR-Mammographie bei 1,5 T , 1996 .

[99]  C A Kelsey,et al.  Benefits versus risks from mammography: A critical reasessment , 1996, Cancer.

[100]  P Aspelin,et al.  Sensitivity and Specificity of MR Mammography with Histopathological Correlation in 250 Breasts , 1996, Acta radiologica.

[101]  R. Fisher,et al.  Breast cancer following treatment for Hodgkin's disease: the need for screening in a young population. Australasian Radiation Oncology Lymphoma Group (AROLG) , 1995, Australasian radiology.

[102]  K. Helzlsouer,et al.  Predictors of and satisfaction with bilateral prophylactic mastectomy. , 1995, Preventive medicine.

[103]  M D Schnall,et al.  Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. , 1995, Radiology.

[104]  T. Rebbeck,et al.  Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. , 1995, JAMA.

[105]  M D Schnall,et al.  MR imaging-guided localization and biopsy of breast lesions: initial experience. , 1994, Radiology.

[106]  P. Tartter,et al.  The significance of family history for patients with carcinoma of the breast. , 1994, Journal of the American College of Surgeons.

[107]  N Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.

[108]  A. Hagenbeek,et al.  Second cancer risk following Hodgkin's disease: a 20-year follow-up study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[109]  N. Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994 .

[110]  C. Steel,et al.  Breast cancer survival in BRCA1 carriers , 1993, The Lancet.

[111]  N. Risch,et al.  Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. , 1992, American journal of epidemiology.

[112]  S. Heywang-Köbrunner,et al.  Contrast-Enhanced MRI of the Breast , 1991 .

[113]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[114]  S. Heywang,et al.  MR imaging of the breast with Gd-DTPA: use and limitations. , 1989, Radiology.

[115]  S. Heywang,et al.  MR imaging of the breast using gadolinium-DTPA. , 1986, Journal of computer assisted tomography.

[116]  S. Heywang,et al.  [Nuclear magnetic resonance tomography in breast cancer diagnosis--present status and future outlook]. , 1985, Digitale Bilddiagnostik.

[117]  M. Goin,et al.  Psychological Reactions to Prophylactic Mastectomy Synchronous with Contralateral Breast Reconstruction , 1982, Plastic and reconstructive surgery.

[118]  C E Land,et al.  Risk of breast cancer following low-dose radiation exposure. , 1979, Radiology.

[119]  J A Koutcher,et al.  NMR in cancer. X. A malignancy index to discriminate normal and cancerous tissue , 1978, Cancer.

[120]  M. King.  Population Genetics of BRCA 1 and BRCA 2 , 2006 .

[121]  V. Pennisi,et al.  Subcutaneous mastectomy data: A final statistical analysis of 1500 patients , 2005, Aesthetic Plastic Surgery.

[122]  Christiane K. Kuhl,et al.  Dynamic Breast Magnetic Resonance Imaging , 2005 .

[123]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[124]  D. Venter,et al.  The pathology of inherited breast cancer , 2002, Pathology.

[125]  J O Barentsz,et al.  Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. , 2001, Journal of the National Cancer Institute.

[126]  Anne,et al.  BREAST CANCER AFTER PROPHYLACTIC BILATERAL MASTECTOMY IN WOMEN WITH A BRCA 1 OR BRCA 2 MUTATION , 2001 .

[127]  A. Heinig,et al.  Interventional MRI of the breast: lesion localisation and biopsy , 2000, European Radiology.

[128]  M Oudkerk,et al.  MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. , 2000, AJR. American journal of roentgenology.

[129]  E. Grabbe,et al.  MRI of the breast in patients with metastatic disease of unknown primary , 1999, European Radiology.

[130]  J. Law.  Cancers detected and induced in mammographic screening: new screening schedules and younger women with family history. , 1997, The British journal of radiology.

[131]  A. Schauer,et al.  [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T]. , 1996, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[132]  A. Ringberg,et al.  A prospective study of psychiatric and psychosocial sequelae of bilateral subcutaneous mastectomy. , 1986, Scandinavian journal of plastic and reconstructive surgery.